E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...

Metabolic syndrome is a disorder of energy use and storage. This syndrome is characterized by central obesity, dyslipidaemia, raised blood pressure and high blood sugar levels. Patients with ...

What is Zollinger-Ellison syndrome? Zollinger-Ellison syndrome (ZES) is a rare digestive disorder. If you have ZES, you likely have 1 or more tumors in the first part of the small intestine, the ...

The term "metabolic syndrome" refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin resistance.

can we prevent the development of the visceral insulin resistance-adiposity syndrome and metabolic cardiorenal disease? Diabetes prevention or delay has been seen with tirzepatide. The future ...

Background: Anxiety and depression are associated with adverse outcomes in cardiorenal syndrome patients undergoing hemodialysis, including decreased quality of life, poorer clinical parameters, and ...

Thank you again for joining us. This is Nihar Desai from the Yale School of Medicine, for the Medscape InDiscussion Cardiorenal Metabolic Syndrome Podcast.

An equation for detecting hyperfiltration that incorporates age but not body surface area may improve early identification of diabetic nephropathy, according to findings from researchers in Japan ...

GLP-1RA and SGLT2 inhibitor combination therapy was associated with better cardiorenal outcomes than monotherapy among patients with type 2 diabetes. The cardiorenal benefits of sodium-glucose ...

The FDA’s Center for Biologics Evaluation and Research (CBER) granted Breakthrough Device Designation for the SCD in cardiorenal syndrome with LVAD in September 2023. “Oftentimes patients with ...